No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease

Neuroscience Letters

Volumn 472, Issue 1, 2010, Pages 16-18

  Collins, Steven J ^a   Schuur, Maaike ^b   Boyd, Alison ^a   Lewis, Victoria ^a   Klug, Genevieve M ^a   McGlade, Amelia ^a   van Oosterhout, Andrew ^b   Breedveld, Guido ^b   Oostra, Ben A ^b   Masters, Colin ^a   Van Duijn, Cornelia M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Creutzfeldt Jakob disease; Dementia; Prion disease; Prion protein gene multiplication

Indexed keywords

PRION PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; FEMALE; GENE LOCUS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GENE DOSAGE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; PRIONS;

EID: 76949087275     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.01.043     Document Type: Article

References (13)

1. Carrard G., Bulteau A.L., Petropoulos I., and Friguet B. Impairment of proteasome structure and function in aging. The International Journal of Biochemistry & Cell Biology 34 (2002) 1461-1474
2. Collins S., Boyd A., Lee J.S., Lewis V., Fletcher A., McLean C.A., Law M., Kaldor J., Smith M.J., and Masters C.L. Creutzfeldt-Jakob disease in Australia 1970-1999. Neurology 59 (2002) 1365-1371
3. Collins S., Law M.G., Fletcher A., Boyd A., Kaldor J., and Masters C.L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353 (1999) 693-697
4. Collins S.J., Lawson V.A., and Masters C.L. Transmissible spongiform encephalopathies. Lancet 363 (2004) 51-61
5. Ibanez P., Bonnet A.M., Debarges B., Lohmann E., Tison F., Pollak P., Agid Y., Durr A., and Brice A. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364 (2004) 1169-1171
6. Kovacs G.G., Puopolo M., Ladogana A., Pocchiari M., Budka H., van Duijn C., Collins S.J., Boyd A., Giulivi A., Coulthart M., Delasnerie-Laupretre N., Brandel J.P., Zerr I., Kretzschmar H.A., de Pedro-Cuesta J., Calero-Lara M., Glatzel M., Aguzzi A., Bishop M., Knight R., Belay G., Will R., and Mitrova E. Genetic prion disease: the EUROCJD experience. Human Genetics 118 (2005) 166-174
7. Ladogana A., Puopolo M., Croes E.A., Budka H., Jarius C., Collins S., Klug G.M., Sutcliffe T., Giulivi A., Alperovitch A., Delasnerie-Laupretre N., Brandel J.P., Poser S., Kretzschmar H., Rietveld I., Mitrova E., Cuesta Jde P., Martinez-Martin P., Glatzel M., Aguzzi A., Knight R., Ward H., Pocchiari M., van Duijn C.M., Will R.G., and Zerr I. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64 (2005) 1586-1591
8. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (1988) 1215
9. Mizuno Y., Hattori N., Kubo S., Sato S., Nishioka K., Hatano T., Tomiyama H., Funayama M., Machida Y., and Mochizuki H. Progress in the pathogenesis and genetics of Parkinson's disease. Philosophical Transactions of the Royal Society of London 363 (2008) 2215-2227
10. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
11. Sleegers K., Brouwers N., Gijselinck I., Theuns J., Goossens D., Wauters J., Del-Favero J., Cruts M., van Duijn C.M., and Van Broeckhoven C. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129 (2006) 2977-2983
12. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
13. Wisniewski K.E., Dalton A.J., McLachlan C., Wen G.Y., and Wisniewski H.M. Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology 35 (1985) 957-961